Results 271 to 280 of about 12,342,164 (400)
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang +16 more
wiley +1 more source
Decoding leprosy: immune response, clinical manifestations and emerging diagnostic approaches. [PDF]
Serrano-Coll H +3 more
europepmc +1 more source
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin +10 more
wiley +1 more source
Editorial: Genes, cells, and macroenvironments: regulating the immune response in extreme conditions. [PDF]
Pennesi G.
europepmc +1 more source
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor.
Cristina Gutiérrez-Vázquez +1 more
semanticscholar +1 more source
ABSTRACT The pathogenesis of Sydenham chorea remains unclear. We report a 10‐year‐old girl presenting with subacute chorea and mild carditis following Streptococcal throat infection. Single‐cell RNA sequencing on 30,794 peripheral immune cells from the patient and two sex‐matched controls revealed nine immune cell clusters.
Velda X. Han +9 more
wiley +1 more source
Vitamin D3 encapsulated in polymeric nanoparticles to dampen the pro-inflammatory immune response. [PDF]
Minnee J +5 more
europepmc +1 more source
ABSTRACT Background Managing long COVID in people with multiple sclerosis and related disorders (pwMSRD) is complex due to overlapping symptoms. To address evidence gaps, we evaluated long COVID susceptibility in pwMSRD versus controls and its associations with multi‐domain function and disability.
Chen Hu +15 more
wiley +1 more source
Understanding the tumor immune microenvironment (TIME) for effective therapy
M. Binnewies +18 more
semanticscholar +1 more source

